ニュース

最新ニュース

23rd 12月 2022

Acticor Biotech provides an update on the US regulatory discussion with the FDA

15th 11月 2022

Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON

Dr Michihiko Wada joins Newton Biocapital as an Advisor, Clinical and Medical Sciences

ニュートンバイオキャピタル、和田道彦博士とフィリップデバッカー博士の参画で、チーム体制をさらに強化

25th 10月 2022

Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)

24th 10月 2022

Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®

20th 10月 2022

Acticor Biotech strenghtens its financial structure

論文掲載のお知らせ：世界初となる”U-to-C”の遺伝子編集をヒト細胞で実現しました

EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells

6
7
8
9
10